Trials / Completed
CompletedNCT03651882
Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections
Intramyometrial and Intravenous Oxytocin Compared to Intravenous Carbetocin for Prevention of Postpartum Hemorrhage in Elective Cesarean Sections - a Monocentric Randomized Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 550 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Objective is to proof non-inferiority of intramyometrial and intravenous oxytocin application compared to intravenous carbetocin for prevention of postpartum hemorrhage in planned, uncomplicated cesarean deliveries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin | Oxytocin given in a combined regimen: after delivery 10 IE of oxytocin are applied intramyometrially and 10 IE of oxytocin are given over an infusion of 1000ml of 0.9% NaCL over 12 hours intravenously. |
| DRUG | Carbetocin | Carbetocin is given 0.1mg intravenously as a bolus after delivery. |
Timeline
- Start date
- 2018-08-07
- Primary completion
- 2022-01-10
- Completion
- 2022-01-10
- First posted
- 2018-08-29
- Last updated
- 2023-05-24
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03651882. Inclusion in this directory is not an endorsement.